(Q39029664)
Statements
Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development (English)
Magdalena Slusarczyk
Monica Huerta Lopez
Malcolm Mason
Sarah Blagden
Emely Thompson